| Primary |
| Vitamin D Decreased |
30.5% |
| Vitamin D Deficiency |
20.3% |
| Temporal Arteritis |
10.2% |
| Osteoporosis |
6.8% |
| Bone Disorder |
3.4% |
| Osteoporosis Prophylaxis |
3.4% |
| Vitamin Supplementation |
3.4% |
| Back Pain |
1.7% |
| Bipolar Disorder |
1.7% |
| Bone Density Abnormal |
1.7% |
| Breast Feeding |
1.7% |
| Heart Valve Replacement |
1.7% |
| Hepatitis C |
1.7% |
| Hypovitaminosis |
1.7% |
| Osteopenia |
1.7% |
| Osteoporotic Fracture |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Supplementation Therapy |
1.7% |
| Vitamin D |
1.7% |
| Vitamin D Abnormal |
1.7% |
|
| Toxicity To Various Agents |
13.3% |
| Medication Error |
11.1% |
| Pain In Extremity |
8.9% |
| Vomiting |
8.9% |
| Rash |
6.7% |
| Blood 25-Hydroxycholecalciferol Increased |
4.4% |
| Diarrhoea |
4.4% |
| Drug Dispensing Error |
4.4% |
| Insomnia |
4.4% |
| Overdose |
4.4% |
| Pain |
4.4% |
| Palpitations |
4.4% |
| Visual Impairment |
4.4% |
| Apnoea |
2.2% |
| Blood Calcium Increased |
2.2% |
| Carpal Tunnel Syndrome |
2.2% |
| Cerebral Haemorrhage |
2.2% |
| Cerebrovascular Accident |
2.2% |
| Chest Pain |
2.2% |
| Decreased Appetite |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
39.1% |
| Drug Use For Unknown Indication |
11.1% |
| Osteoporosis |
5.7% |
| Hypertension |
4.9% |
| Drug Exposure During Pregnancy |
4.7% |
| Depression |
3.6% |
| Pain |
3.3% |
| Hypothyroidism |
3.0% |
| Blood Cholesterol Increased |
2.7% |
| Ill-defined Disorder |
2.7% |
| Asthma |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Supplementation Therapy |
2.1% |
| Fibromyalgia |
2.0% |
| Prophylaxis |
2.0% |
| Vitamin Supplementation |
1.9% |
| Maternal Exposure During Pregnancy |
1.7% |
| Diabetes Mellitus |
1.6% |
| Osteoporosis Prophylaxis |
1.6% |
| Vitamin D Deficiency |
1.6% |
|
| Completed Suicide |
11.4% |
| Vomiting |
9.3% |
| Toxicity To Various Agents |
7.9% |
| Drug Interaction |
5.7% |
| Pain |
5.7% |
| Tendonitis |
5.7% |
| Drug Ineffective |
5.0% |
| Pain In Extremity |
5.0% |
| Nephrocalcinosis |
4.3% |
| Rash |
4.3% |
| Restless Legs Syndrome |
4.3% |
| Visual Impairment |
4.3% |
| Weight Increased |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Constipation |
3.6% |
| Tremor |
3.6% |
| Dizziness |
2.9% |
| Headache |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Pulmonary Hypertension |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.4% |
| Drug Use For Unknown Indication |
8.8% |
| Osteoporosis |
6.6% |
| Hypertension |
5.6% |
| Rheumatoid Arthritis |
5.5% |
| Pain |
3.8% |
| Crohn's Disease |
3.5% |
| Vitamin Supplementation |
3.4% |
| Multiple Sclerosis |
2.9% |
| Depression |
2.4% |
| Supplementation Therapy |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Blood Cholesterol Increased |
2.2% |
| Prophylaxis |
2.2% |
| Asthma |
1.8% |
| Diabetes Mellitus |
1.7% |
| Anxiety |
1.5% |
| Atrial Fibrillation |
1.4% |
| Multiple Myeloma |
1.3% |
| Hypothyroidism |
1.2% |
|
| Vomiting |
9.7% |
| Weight Decreased |
9.3% |
| Nausea |
6.3% |
| Pain |
6.1% |
| Weight Increased |
5.9% |
| Pain In Extremity |
5.4% |
| Flushing |
5.0% |
| Drug Ineffective |
4.9% |
| Pruritus |
4.9% |
| Death |
4.6% |
| Urinary Tract Infection |
4.5% |
| Pneumonia |
4.2% |
| Fatigue |
4.2% |
| Injection Site Pain |
4.1% |
| Headache |
3.9% |
| Pyrexia |
3.6% |
| Dyspnoea |
3.5% |
| Rash |
3.5% |
| Diarrhoea |
3.3% |
| Tremor |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
27.8% |
| Vitamin D Deficiency |
8.9% |
| Drug Use For Unknown Indication |
7.8% |
| Blood Cholesterol Abnormal |
5.6% |
| Vitamin Supplementation |
5.6% |
| Depression |
4.4% |
| Systemic Candida |
4.4% |
| Back Disorder |
3.3% |
| Back Pain |
3.3% |
| Bladder Obstruction |
3.3% |
| Fibromyalgia |
3.3% |
| Hypertension |
3.3% |
| Irritable Bowel Syndrome |
3.3% |
| Blood Cholesterol Increased |
2.2% |
| Blood Pressure High |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Hypersensitivity |
2.2% |
| Major Depression |
2.2% |
| Musculoskeletal Pain |
2.2% |
| Neck Pain |
2.2% |
|
| Drug Interaction |
14.7% |
| Vitamin D Deficiency |
14.7% |
| International Normalised Ratio Increased |
8.8% |
| Somnolence |
8.8% |
| Toxicity To Various Agents |
8.8% |
| Dizziness |
2.9% |
| Drug Administration Error |
2.9% |
| Drug Effect Decreased |
2.9% |
| Feeling Abnormal |
2.9% |
| Heart Rate Increased |
2.9% |
| Hepatic Enzyme Increased |
2.9% |
| Low Density Lipoprotein Increased |
2.9% |
| Musculoskeletal Discomfort |
2.9% |
| Nephrocalcinosis |
2.9% |
| Neutropenia |
2.9% |
| Osteopenia |
2.9% |
| Pancreatitis |
2.9% |
| Thyroid Function Test Abnormal |
2.9% |
| Treatment Noncompliance |
2.9% |
| Type 1 Diabetes Mellitus |
2.9% |
|
